Making the diagnosis of fungal infection: when to start treatment

Area of Science:

• Oncology
• Infectious Diseases
• Mycology

Background:

• Cancer patients undergoing chemotherapy or stem cell transplantation face increased risk of invasive fungal infections due to profound immunosuppression.
• Invasive mycoses in cancer patients have a poor prognosis if not diagnosed and treated early.
• Opportunistic fungal infections present diagnostic challenges, often lacking specific clinical signs beyond fever.

Purpose of the Study:

• To highlight the diagnostic difficulties of invasive fungal infections in cancer patients.
• To emphasize the need for accurate and timely diagnosis for improved patient outcomes.
• To review current diagnostic approaches and their limitations.

Main Methods:

• Review of clinical presentations and diagnostic challenges in cancer patients with fungal infections.
• Discussion of the utility and limitations of microbiological cultures.
• Evaluation of emerging diagnostic methods like antigen detection and molecular techniques.

Main Results:

• Clinical diagnosis is often delayed, with fever being the most common sign.
• Fungal cultures are frequently negative, and interpretation of positive results requires careful consideration of colonization versus infection.
• Distinguishing between fungal colonization and true infection remains a significant hurdle.
• Molecular methods for fungal antigen detection show promise but require further validation.

Conclusions:

• Early and accurate diagnosis of invasive fungal infections in cancer patients is critical for effective management and improved survival.
• A combination of clinical, microbiological, histological, and serological data is often necessary for diagnosis.
• Further research is needed to refine diagnostic strategies, particularly for differentiating colonization from infection and validating new molecular techniques.